A series of potent HIV-protease inhibitors has been prepared. Several
of the newly synthesized compounds showed high plasma levels after ora
l administration to animals. Based on the overall biological profile,
CGP 61755 was chosen for further preclinical evaluation. For this comp
ound, a 10 step synthesis potentially suitable for large scale product
ion was developed.